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Purpose
To examine the remission rates and functional out-
comes in an inception cohort of patients with juvenile
idiopathic arthritis (JIA).
Methods
The Research in Arthritis in Canadian Children, empha-
sizing Outcomes (ReACCh-Out) cohort is a 16-centre
inception cohort of patients with JIA enrolled within 1
year of diagnosis. All patients who completed 5 six-
monthly study visits from baseline to 24 months were
included in this analysis. Disease activity and functional
measures were collected at each visit. Criteria for disease
remission status in this study were defined by Wallace et
al (2006) modified by omission of ESR or CRP due to
incomplete data. Inactive disease (ID) was defined as no
active joints, physician global assessment 0, and no active
extra-articular disease; clinical remission on medications
(CRM) is ID for ≥ 6 months on medications; and clinical
remission (CR) is ID for ≥ 12 months off medications.
Health status was measured using the Juvenile Arthritis
Quality of Life Questionnaire (JAQQ), and functional sta-
tus using the Child Health Assessment Questionnaire
(CHAQ).
Results
Data for 347 of 1574 patients enrolled in the ReACCh-Out
cohort was available for analysis. Median age of disease
onset was 7.5 yr (IQR 3,11), with 35% oligoarticular, 22%
polyarticular RF negative, 13% enthesitis related arthritis,
8% systemic, 8% undifferentiated, and 7% for each
polyarticular RF positive and psoriatic subtypes. The per-
centage of patients with ID was 33% at 6 months, 39% at
12 months and 49% at 24 months; CRM increased from
4% at 6 months to 18% at 12 months and 26% at 24
months, while CR at 24 months was 7%. Differences in
remission rates were evident amongst the JIA subtypes by
12 months, with the highest remission rates in oligoarthri-
tis and lowest in the RF positive polyarthritis (CRM of 29%
and 4% respectively). Even when ID was not reached, a
decrease in active joint count was noted in all JIA subtypes.
CHAQ and JAQQ scores improved in all patients as early
as 6 months. Differences were also evident amongst the
JIA subtypes with the best 24 month median scores in oli-
goarthritis patients (CHAQ=0, JAQQ=1.35) compared
with the worse scores in RF+ polyarthritis patients
(CHAQ=0.625, JAQQ=2.35).
Conclusion
While active joint counts and functional outcomes
improved within the first 24 months, disease remission
rates differed amongst JIA subtypes, and CRs are rare.
The remission rates derived from our inception cohort
of JIA patients will assist in family counseling, pinpoint
subgroups requiring aggressive therapy and inform the
design of clinical trials.
Disclosure
Shirley M.L. Tse: None; Lori B. Tucker: None; Gaelle
Chédeville: None; Janet E. Ellsworth: None; Jaime Guz-
man: None; Kim Morishita: None; Rosie Scuccimarri:
None; Natalie J. Shiff: None; Ciaran M. Duffy: None;
Rae S.M. Yeung: None; Kiem G. Oen: None.
5The Hospital for Sick Children, Toronto, ON, Canada
Full list of author information is available at the end of the article
Tse et al. Pediatric Rheumatology 2012, 10(Suppl 1):A60
http://www.ped-rheum.com/content/10/S1/A60
© 2012 Tse et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Author details
1BC Children’s Hospital, Vancouver, BC, Canada. 2Montreal Children’s Hospital,
Montreal, QC, Canada. 3Royal University Hospital, Saskatoon, SK, Canada.
4Stollery Children’s Hospital, Edmonton, AB, Canada. 5The Hospital for Sick
Children, Toronto, ON, Canada. 6UBC and BC Children’s Hospital, Vancouver,
BC, Canada. 7University of Manitoba, Winnipeg, MB, Canada.
Published: 13 July 2012
doi:10.1186/1546-0096-10-S1-A60
Cite this article as: Tse et al.: Two year remission rates and functional
outcomes in an inception cohort of Canadian children with juvenile
idiopathic arthritis. Pediatric Rheumatology 2012 10(Suppl 1):A60.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Tse et al. Pediatric Rheumatology 2012, 10(Suppl 1):A60
http://www.ped-rheum.com/content/10/S1/A60
Page 2 of 2
